Please assess the completion status of the following clinical trial:

Trial Title: Early Detection of Cardiac Toxicity in Childhood Cancer Survivors

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: COHORT
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Subjects that have received anthracycline based chemotherapy~* Age: 8 years old - 25 years old~* Subjects that do not require sedation for cardiac MRI.~* Subjects must have completed treatment in the last 10 years~Exclusion Criteria:~* Patients with significant congenital heart defects~* Patients with renal injury or renal failure, defined as an estimated glomerular filtration rate \[eGFR\] \<30 ml/min/1.73 m2 body surface area), as previously calculated)~* Patients that require sedation for a cardiac MRI~* Subjects that are pregnant or lactating~* Patients with contraindications to a cardiac MRI:~* Cardiac pacemaker or implantable defibrillator~* Cerebral aneurysm clip~* Neural stimulator~* Metallic ocular foreign body~* Any implanted device (i.e. insulin pump, drug infusion device)~* Claustrophobia~* Metal shrapnel or bullet~* Investigator assessment of inability to comply with protocol~* Unable/unwilling to lie still throughout the research procedure~* Persons with cognitive impairment

- Gender: ALL
- Minimum Age: 8 Years
- Maximum Age: 25 Years
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).